Neuroprotective roles of klotho: Molecular pathways and therapeutic implications for cognitive health in neurological and psychiatric diseases
Open Access
- 15 April 2026
- journal article
- review article
- Published by Wiley in Experimental Physiology
- Vol. 111 (7) , 3179-3190
Abstract
Klotho, a pleiotropic protein initially identified for its role in kidney function, has garnered significant attention for its neuroprotective properties in various neurodegenerative diseases. It regulates key processes, such as oxidative stress, neuroinflammation, synaptic plasticity and myelination, all crucial for maintaining neuronal integrity and cognitive function. Preclinical studies demonstrate that klotho enhances amyloid‐β and tau clearance, stabilizes synaptic function, supports oligodendrocyte maturation and mitigates excitotoxicity. Clinical findings show that higher α‐klotho levels are associated with slower cognitive decline in Alzheimer's and Parkinson's diseases, improved outcomes in multiple sclerosis and better recovery after stroke. Notably, the protective effects of klotho appear most pronounced in individuals with high genetic or pathological risks, such as apolipoprotein E ε4 carriers in Alzheimer's disease. Despite these promising insights, the clinical application of klotho‐based therapies is hindered by variability in biomarker assays, challenges in crossing the blood–brain barrier, and the need for precision‐based interventions tailored to individual genetic profiles. Current strategies to enhance klotho activity include lifestyle changes, pharmacological agents, recombinant protein delivery and gene therapy. Although challenges remain, klotho stands as a potential therapeutic target for mitigating cognitive decline and promoting brain health across a range of neurodegenerative and cerebrovascular conditions.Keywords
This publication has 70 references indexed in Scilit:
- Serum alpha klotho levels in Parkinson’s DiseaseNeurological Sciences, 2024
- Klotho: molecular mechanisms and emerging therapeutics in central nervous system diseasesMolecular Biology Reports, 2024
- KLOTHO KL‐VS heterozygosity is associated with diminished age‐related neuroinflammation, neurodegeneration, and synaptic dysfunction in older cognitively unimpaired adultsAlzheimer's & Dementia, 2024
- Relationships between KLOTHO and APOE4‐associated β‐amyloid and tau alterations across AD continuumAlzheimer's & Dementia, 2023
- Klotho protein concentrations as a function of sex, APOE, family history or Alzheimer’s disease biomarker status in an at‐risk cohortAlzheimer's & Dementia, 2023
- Association of Klotho Protein Levels and KL-VS Heterozygosity With Alzheimer Disease and Amyloid and Tau BurdenJAMA Network Open, 2022
- Peripheral Klotho and Parkinson's DiseaseMovement Disorders, 2021
- Klotho Is Neuroprotective in the Superoxide Dismutase (SOD1G93A) Mouse Model of ALSJournal of Molecular Neuroscience, 2019
- Klotho protein in neurodegenerative disordersNeurological Sciences, 2018
- The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced DemyelinationJournal of Molecular Neuroscience, 2015